Cargando…

Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population

OBJECTIVE: To describe the characteristics, treatment patterns, health care resource utilization (HCRU), and cost of care for members of a large United States (US) health insurance plan with lupus nephritis (LN). METHODS: A retrospective observational study was conducted using a health insurance pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartels-Peculis, Laura, Sharma, Ajay, Edwards, Alison M, Sanyal, Anirudh, Connolly-Strong, Erin, Nelson, Winnie W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319534/ https://www.ncbi.nlm.nih.gov/pubmed/32607019 http://dx.doi.org/10.2147/OARRR.S248750

Ejemplares similares

The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
por: Hunnicutt, Jacob N., et al.
Publicado: (2023)

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
por: Bell, Christopher F, et al.
Publicado: (2023)

Cost of hospitalization for firearm injuries by firearm type, intent, and payer in the United States
por: Peek-Asa, Corinne, et al.
Publicado: (2017)

Healthcare resource use and cost burden of urinary incontinence to United States payers
por: Datar, Manasi, et al.
Publicado: (2022)

Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden
por: Katz, Patricia, et al.
Publicado: (2020)

Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia
por: Wen, Qiong, et al.
Publicado: (2022)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

Treatment for Severe Lupus Nephritis: A Cost-Effectiveness Analysis in China
por: Dai, Zonglin, et al.
Publicado: (2021)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Targeting Regulatory T Cells for Therapy of Lupus Nephritis
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

Coccidioidomycosis in adolescents with lupus nephritis
por: Yorgin, Peter D., et al.
Publicado: (2001)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Geographic variation in cesarean delivery in the United States by payer
por: Henke, Rachel Mosher, et al.
Publicado: (2014)

Increase in direct costs for health systems due to lupus nephritis: the case of Colombia
por: Prada, Sergio I, et al.
Publicado: (2022)

Association between the unemployment rate and inpatient cost per discharge by payer in the United States, 2005–2010
por: Maeda, Jared Lane K, et al.
Publicado: (2014)

Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses
por: Cai, Christopher, et al.
Publicado: (2020)

MicroRNA's role as biomarkers of lupus nephritis in children
por: Abulaban, Khalid, et al.
Publicado: (2014)

Control of lupus nephritis by changes of gut microbiota
por: Mu, Qinghui, et al.
Publicado: (2017)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
por: Schwartzman-Morris, Julie, et al.
Publicado: (2012)

Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

East-Asian lupus nephritis in the Hopkins Lupus Cohort
por: Petri, Michelle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3166lc4bmr6jtcjo1u17vlb1rk